Results 1 to 10 of about 5,062,316 (181)
The EANM guideline on radioiodine therapy of benign thyroid disease. [PDF]
Eur J Nucl Med Mol Imaging, 2023 This document provides the new EANM guideline on radioiodine therapy of benign thyroid disease. Its aim is to guide nuclear medicine physicians, endocrinologists, and practitioners in the selection of patients for radioiodine therapy. Its recommendations
Campennì A +7 more
europepmc +2 more sources
World Journal of Surgical Oncology, 2019 Background The prognosis for patients with advanced differentiated thyroid carcinoma (ADTC) with disseminated distant metastases is very poor. Tyrosine kinase inhibitors targeting tumor angiogenesis have been shown to improve progression-free survival in
Nai-Wei Sheu +5 more
doaj +2 more sources
Identifying risk factors associated with refractoriness to radioiodine therapy in differentiated thyroid cancer [PDF]
Archives of Endocrinology and MetabolismObjective: To identify factors potentially associated with radioiodine-refractory disease among patients treated for differentiated thyroid carcinoma at a referral center in Northeastern Brazil.
Fernando Barros Costa Ribeiro +9 more
doaj +2 more sources
Response to Radioiodine Therapy for Thyrotoxicosis: Disparate Outcomes for an Indigenous Population
International Journal of Endocrinology, 2016 Despite 70 years of experience treating thyrotoxic patients with radioiodine not all patients are successfully treated by a single dose. Multiple factors predicting radioiodine efficacy have been reported.
Jade A. U. Tamatea +2 more
doaj +2 more sources
World Journal of Nuclear Medicine, 2016 Iodine-131 (I-131) therapy is one of the conventional approaches in the treatment of patients with differentiated thyroid carcinoma (DTC). The radioiodine agents also accumulate in the other organs that cause pain and damage to the patients.
Mehran Pashnehsaz +6 more
doaj +2 more sources
Radioiodine therapy in patients with Graves′ disease and the effects of prior carbimazole therapy
Indian Journal of Endocrinology and Metabolism, 2014 The use of radioiodine as the first line of treatment in Graves′ disease is restricted in India because of its limited availability and an unrealistic risk perception associated with it.
Arun Karyampudi +4 more
doaj +2 more sources
Ultrasonography Echotexture as a surrogate for Sialadenitis secondary to 131I Radioiodine Therapy for differentiated Thyroid Cancer: a review and metaanalysis [PDF]
Clinics, 2020 To systematically review and analyze the medical literature to assess ultrasonography echotexture changes in thyroid cancer patients for the detection of chronic sialadenitis caused by radioiodine therapy.
Graziele Aparecida Simões Lima +7 more
doaj +3 more sources
Improving 131I Radioiodine Therapy By Hybrid Polymer-Grafted Gold Nanoparticles
International Journal of Nanomedicine, 2019 Background Human trials combining external radiotherapy (RT) and metallic nanoparticles are currently underway in cancer patients. For internal RT, in which a radioisotope such as radioiodine is systemically administered into patients, there is also a ...
Le Goas M +12 more
openalex +3 more sources
The history of radioiodine therapy beginnings
Клиническая и экспериментальная тиреоидология, 2016 This report contains historical review of radioiodine therapy invention and clinical implementation for the treatment of patients with diffuse toxic goiter and differentiated thyroid cancer.
Pavel Olegovich Rumiantsev +1 more
doaj +2 more sources
Frontiers in Endocrinology, 2017 Although most differentiated thyroid cancers show excellent prognosis, treating radioiodine refractory differentiated thyroid cancer (RR-DTC) is challenging. Various therapies, including chemotherapy, radiotherapy, and targeted therapy, have been applied
Chae Moon Hong, Byeong-Cheol Ahn
doaj +2 more sources